Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Eichenbaum

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Opinion in Ophthalmology|February 29, 2024
Geographic atrophy: current and future therapeutic agents and practical considerations for retinal specialistsPriya Vakharia, David Eichenbaum
Retinal Cases & Brief Reports|November 11, 2014
Neovascularization of the optic disk and vitreous hemorrhage after immune recovery and treatment of cytomegalovirus retinitis in an HIV-positive patientJeffrey R Golen, David Eichenbaum
Current Opinion in Ophthalmology|May 9, 2026
Geographic atrophy: From slowing lesions to preserving visionKaitlyn Mang, David Eichenbaum, Priya Vakharia
Ophthalmic Surgery, Lasers & Imaging Retina|January 7, 2015
Geographic atrophy: clinical impact and emerging treatmentsHershel R Patel, Seenu M Hariprasad, David Eichenbaum
Retina (Philadelphia, Pa.)|April 27, 2018
OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONArshad M Khanani, David Eichenbaum, Patricio G Schlottmann, et al.
Ophthalmology. Retina|January 8, 2021
ReplyHannah J Yu, Daniel F Kiernan, David Eichenbaum, et al.
Ophthalmology. Retina|August 19, 2020
Home Monitoring of Age-Related Macular Degeneration: Utility of the ForeseeHome Device for Detection of NeovascularizationHannah J Yu, Daniel F Kiernan, David Eichenbaum, et al.
Ophthalmology. Retina|August 16, 2023
The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: Intraocular Pressure-Related Effects over 36 MonthsDaniel B Roth, David Eichenbaum, Deepika Malik, et al.
Ophthalmology and Therapy|June 1, 2024
Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative ReviewIan M Leitch, Michael Gerometta, David Eichenbaum, et al.
Journal of Ophthalmic Inflammation and Infection|September 19, 2024
Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patientsRobert A Sisk, Daniel F Kiernan, David Almeida, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Opinion in Ophthalmology|February 29, 2024
Geographic atrophy: current and future therapeutic agents and practical considerations for retinal specialistsPriya Vakharia, David Eichenbaum
Retinal Cases & Brief Reports|November 11, 2014
Neovascularization of the optic disk and vitreous hemorrhage after immune recovery and treatment of cytomegalovirus retinitis in an HIV-positive patientJeffrey R Golen, David Eichenbaum
Current Opinion in Ophthalmology|May 9, 2026
Geographic atrophy: From slowing lesions to preserving visionKaitlyn Mang, David Eichenbaum, Priya Vakharia
Ophthalmic Surgery, Lasers & Imaging Retina|January 7, 2015
Geographic atrophy: clinical impact and emerging treatmentsHershel R Patel, Seenu M Hariprasad, David Eichenbaum
Retina (Philadelphia, Pa.)|April 27, 2018
OPTIMAL MANAGEMENT OF PIGMENT EPITHELIAL DETACHMENTS IN EYES WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATIONArshad M Khanani, David Eichenbaum, Patricio G Schlottmann, et al.
Ophthalmology. Retina|January 8, 2021
ReplyHannah J Yu, Daniel F Kiernan, David Eichenbaum, et al.
Ophthalmology. Retina|August 19, 2020
Home Monitoring of Age-Related Macular Degeneration: Utility of the ForeseeHome Device for Detection of NeovascularizationHannah J Yu, Daniel F Kiernan, David Eichenbaum, et al.
Ophthalmology. Retina|August 16, 2023
The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema: Intraocular Pressure-Related Effects over 36 MonthsDaniel B Roth, David Eichenbaum, Deepika Malik, et al.
Ophthalmology and Therapy|June 1, 2024
Vascular Endothelial Growth Factor C and D Signaling Pathways as Potential Targets for the Treatment of Neovascular Age-Related Macular Degeneration: A Narrative ReviewIan M Leitch, Michael Gerometta, David Eichenbaum, et al.
Journal of Ophthalmic Inflammation and Infection|September 19, 2024
Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patientsRobert A Sisk, Daniel F Kiernan, David Almeida, et al.
Pageof 3